European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

EAU25: Highlights from Day 2

See the highlights of EAU25’s day 2, including session reports on clinical decision-making in patients with overactive bladder (OAB) and benign prostatic obstruction (BPO), and how biomarkers are advancing treatment. Watch an EAUTV panel discussion on OAB and BPO, view a webcast, photos of the day, and what’s coming up on Sunday!

Sun, 23 Mar 2025
EAU 25EAU Annual CongressBPO ManagementOAB
Enlarge image

Must-view webcast:

Patient with high-risk localised PCa cT3b N0 M0 ISUP Grade Group – Case presentation
P.K-F. Chiu, Hong Kong (HK)
Watch the webcast

OAB and BPO: The link, non-invasive approaches, surgical strategies, and shared decision-making
What is the relationship between BPO and OAB? Define the non-invasive work-up for a patient with both BPE and OAB symptoms. Which surgery is best for BPO/OAB patients? The Plenary Session ‘Navigating the Urge: Clinical Decision-Making in Patients with Overactive Bladder (OAB) and Benign Prostatic Obstruction (BPO)’ addressed these questions and the importance of shared decision-making with your patients, today. Read article here.

From the congress floor in Madrid
Check out this EAU25 Awards album to see this year’s winners at the 40th Annual EAU Congress! We also have some general impressions from Day 2 for you. Share your photos and stories on Instagram as well.

How are biomarkers advancing treatment?
The plenary session “Biomarkers to guide peri-operative management in onco-urology,” reviewed the integration of biomarkers in managing prostate, bladder, and kidney cancers. Experts discussed the potential of ctDNA and DNA damage response genes in predicting treatment outcomes.

What’s coming this Sunday

  • 08:00 – 10:00 Plenary Session: Enhancing quality of care in prostate cancer
  • 08:00 – 10:00 Plenary Session:  Help… Challenges and nightmares in endourology
  • 10:00 – 10:30 Game Changer Session: Learn about and discuss innovative techniques that potentially impact established methods used to diagnose prostate cancer
  • 10:00 – 10:30 Game Changer Session: Hear about 2 of the most impactful abstracts submitted to EAU 2025

Access all EAU25 scientific content
All webcasts, videos, posters and full-text abstracts are currently accessible via the EAU25 Resource Centre wherein delegates have full access. If you did not attend the congress, you can still register for on-demand access to explore all of EAU25 scientific content (accreditation is no longer valid).

Share this article

Suggested for you

See all
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer